Search by Drug Name or NDC
NDC 00517-0401-25 Atropine Sulfate 0.4 mg/mL Details
Atropine Sulfate 0.4 mg/mL
Atropine Sulfate is a INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Regent, Inc.. The primary component is ATROPINE SULFATE.
Product Information
| NDC | 00517-0401 |
|---|---|
| Product ID | 0517-0401_f44c9118-ef54-46cd-ab36-16547c377314 |
| Associated GPIs | 49101010102020 |
| GCN Sequence Number | 004820 |
| GCN Sequence Number Description | atropine sulfate VIAL 0.4 MG/ML INJECTION |
| HIC3 | J2A |
| HIC3 Description | BELLADONNA ALKALOIDS |
| GCN | 18672 |
| HICL Sequence Number | 002004 |
| HICL Sequence Number Description | ATROPINE SULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Atropine Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Atropine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Active Ingredient Strength | 0.4 |
| Active Ingredient Units | mg/mL |
| Substance Name | ATROPINE SULFATE |
| Labeler Name | American Regent, Inc. |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2022-12-31 |
Package
NDC 00517-0401-25 (00517040125)
| NDC Package Code | 0517-0401-25 |
|---|---|
| Billing NDC | 00517040125 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0517-0401-25) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 1992-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |